These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37929348)

  • 21. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells.
    Zhang WJ; Luo C; Huang C; Pu FQ; Zhu JF; Zhu ZM
    Eur J Pharmacol; 2021 May; 899():174041. PubMed ID: 33737010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inorganic pyrophosphatase 1 activates the phosphatidylinositol 3-kinase/Akt signaling to promote tumorigenicity and stemness properties in colorectal cancer.
    Niu T; Zhu J; Dong L; Yuan P; Zhang L; Liu D
    Cell Signal; 2023 Aug; 108():110693. PubMed ID: 37141926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
    Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB
    Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer.
    Ding C; Tang W; Wu H; Fan X; Luo J; Feng J; Wen K; Wu G
    Cancer Lett; 2019 Feb; 442():383-395. PubMed ID: 30472186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Decursin affects proliferation, apoptosis, and migration of colorectal cancer cells through PI3K/Akt signaling pathway].
    Yang Y; Hu YE; Zhao MY; Jiang YF; Fu X; You FM
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2334-2342. PubMed ID: 37282862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
    J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
    Li Q; Tang H; Hu F; Qin C
    J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
    Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
    Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.
    Feng Y; Ji D; Huang Y; Ji B; Zhang Y; Li J; Peng W; Zhang C; Zhang D; Sun Y; Xu Z
    Oncol Rep; 2020 Mar; 43(3):864-876. PubMed ID: 32020212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway.
    Chen Z; Wang C; Dong H; Wang X; Gao F; Zhang S; Zhang X
    Mol Med; 2020 Jan; 26(1):14. PubMed ID: 32000660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway.
    Ao R; Guan L; Wang Y; Wang JN
    J Cell Biochem; 2018 Jun; 119(6):4420-4434. PubMed ID: 29143985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway.
    Ma Q; Lu Y; Gu Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819841433. PubMed ID: 30947633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
    Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
    Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1.
    Li J; Qi Y
    Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-93/HMGB3 regulatory axis exerts tumor suppressive effects in colorectal carcinoma cells.
    Gu M; Jiang Z; Li H; Peng J; Chen X; Tang M
    Exp Mol Pathol; 2021 Jun; 120():104635. PubMed ID: 33773992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MOR promotes epithelial-mesenchymal transition and proliferation via PI3K/AKT signaling pathway in human colorectal cancer.
    Gao L; Yang L; He Y; Liu Y; Xu P; Zhang J; Dai S; Luo X; Sun Z
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 55(1):72-80. PubMed ID: 35983971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway.
    Zhao P; Guan HT; Dai ZJ; Ma YG; Liu XX; Wang XJ
    Oncol Res; 2016 Oct; 24(6):437-445. PubMed ID: 28281964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
    Qin A; Qian W
    Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.